Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 2067 Radiotherapy 1990 Cisplatin 1856 Carboplatin 1560 Gemcitabine 1454 Paclitaxel 1320 Bevacizumab 1320 pembrolizumab 1237 Docetaxel 1227 Oxaliplatin 1184 Capecitabine 1176 Fluorouracil 1083 Dexamethasone 979 Magnetic Resonance Spectroscopy 971 Nivolumab 936 Rituximab 929 Drug Therapy 915 Surveys and Questionnaires 898 Doxorubicin 845 Etoposide 843 Radiosurgery 816 Blood Specimen Collection 816 Irinotecan 784 Cytarabine 743 fludarabine 726 Leucovorin 684 Surgical Procedures, Operative 639 Lenalidomide 618 Biopsy 594 fludarabine phosphate 569

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × finerenone × Clear all

NCT06818305 2025-12-11

EmFin-Nx

Jinling Hospital, China

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡